Results 21 to 30 of about 18,220 (284)

Epidemiologic features in patients with antihistamine-resistant chronic urticaria

open access: yesRevista Alergia México, 2015
Background: Current information on the particular features of patients suffering chronic spontaneous urticaria refractory to treatment is limited.  Objective: To investigate demographic and clinical characteristics in patients with refractory chronic ...
Mario Sánchez-Borges   +2 more
doaj   +1 more source

Изменение клеточного и гуморального иммунитета у пациентов с холодовой и хронической спонтанной крапивницей [PDF]

open access: yes, 2014
холодовая крапивницаКРАПИВНИЦАИММУНИТЕТ ГУМОРАЛЬНЫЙАНТИТЕЛ ОБРАЗОВАНИЕИММУНИТЕТ КЛЕТОЧНЫЙхроническая спонтанная ...
Янченко, В. В.   +1 more
core   +2 more sources

Urticaria and mimickers of urticaria

open access: yesFrontiers in Allergy, 2023
Urticaria is a common skin condition encountered across various specialties in medicine, especially in dermatology and allergy/immunology practice. It has a heterogeneous presentation hence it is unsurprising that many skin conditions may be confused ...
Jie Shen Fok   +4 more
doaj   +1 more source

Etiology of chronic urticaria: the Ecuadorian experience [PDF]

open access: yes, 2018
Background: The purpose of this study was to identify chronic urticaria (CU) etiologies and treatment modalities in Ecuador. We propose that the sample distribution fits the expected one, and that there is an association between the etiology and its ...
Cano, J.   +9 more
core   +1 more source

Omalizumab rapidly improves angioedema‐related quality of life in adult patients with chronic spontaneous urticaria: X‐ACT study data [PDF]

open access: yes, 2018
Background: The X‐ACT study aimed to examine the effect of omalizumab treatment on quality of life (QoL) in chronic spontaneous urticaria (CSU) patients with angioedema refractory to high doses of H1‐antihistamines. Methods: In X‐ACT, a phase III, double‐
Barbosa   +29 more
core   +1 more source

The many faces of pediatric urticaria

open access: yesFrontiers in Allergy, 2023
Urticaria is a common disease that can affect individuals of all age groups, with approximately one-quarter of the population experiencing it at least once in their lifetime.
Bulent Enis Sekerel   +4 more
doaj   +1 more source

Differential Diagnoses of Systemic Mastocytosis in Routinely Processed Bone Marrow Biopsy Specimens: A Review [PDF]

open access: yes, 2010
Diagnosis of systemic mastocytosis (SM) is mainly based on the morphological demonstration of compact mast cell infiltrates in various tissue sites. In almost all patients such infiltrates are detected in the bone marrow.
Horny, H. -P., Sotlar, K., Valent, P.
core   +1 more source

Tolerance to alternative cyclooxygenase-2 inhibitors in nonsteroidal anti-inflammatory drug hypersensitive patients [PDF]

open access: yes, 2013
Background: Non-steroidal anti-inflammatory drugs (NSAIDs) frequently cause adverse drug reactions. Many studies have shown that drugs which selectively inhibit the cyclooxygenase-2 enzyme (COX-2) are safe alternatives in the majority of patients ...
Bruijnzeel-Koomen, C.A.   +3 more
core   +3 more sources

Cardiac safety of second-generation H1 -antihistamines when updosed in chronic spontaneous urticaria [PDF]

open access: yes, 2019
The symptoms of chronic urticaria, be it chronic spontaneous urticaria (CSU) or chronic inducible urticaria (CindU), are mediated primarily by the actions of histamine on H1 receptors located on endothelial cells (the weal) and on sensory nerves ...
Cataldi, M   +3 more
core   +1 more source

Chronic spontaneous urticaria – a management pathway for patients with chronic spontaneous urticaria [PDF]

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2015
SummaryChronic spontaneous urticaria (CSU) is a common and challenging disease, especially with respect to healthcare provision in the context of the German statutory health insurance system. If treatment with second‐generation antihistamines is unsuccessful, current guidelines recommend further therapeutic options. However, most of these are off‐label.
Christian, Termeer   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy